KCM
TEVA icon

Kornitzer Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Kornitzer Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,320
Closed -$376K – 474
2017
Q2 		$376K Buy
11,320
+1,870
+20% +$57.9K 0.01% 446
2017
Q1 		$303K Sell
9,450
-16,330
-63% -$557K 0.01% 445
2016
Q4 		$935K Sell
25,780
-33,700
-57% -$1.35M 0.02% 379
2016
Q3 		$2.74M Sell
59,480
-75
-0.1% -$3.91K 0.05% 287
2016
Q2 		$2.99M Sell
59,555
-68
-0.1% -$3.62K 0.05% 277
2016
Q1 		$3.19M Sell
59,623
-47,200
-44% -$2.77M 0.05% 272
2015
Q4 		$7.01M Sell
106,823
-10,882
-9% -$672K 0.11% 229
2015
Q3 		$6.65M Sell
117,705
-2,100
-2% -$136K 0.11% 235
2015
Q2 		$7.08M Buy
119,805
+50
+0% +$3.08K 0.1% 239
2015
Q1 		$7.46M Buy
119,755
+1,980
+2% +$115K 0.09% 226
2014
Q4 		$6.77M Buy
117,775
+2,050
+2% +$114K 0.08% 232
2014
Q3 		$6.22M Buy
115,725
+4,025
+4% +$213K 0.07% 236
2014
Q2 		$5.86M Buy
111,700
+8,300
+8% +$424K 0.06% 250
2014
Q1 		$5.46M Buy
103,400
+31,200
+43% +$1.44M 0.06% 261
2013
Q4 		$2.89M Buy
72,200
+56,495
+360% +$2.22M 0.03% 306
2013
Q3 		$593K Hold
15,705
– – 0.01% 361
2013
Q2 		$616K Buy
+15,705
New +$612K 0.01% 354

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Kornitzer Capital Management's TEVA Position: Q3 2017 in Review

Kornitzer Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 11,320 shares — an estimated $376K sold.

Kornitzer Capital Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $7.46M in Q1 2015. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Kornitzer Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Kornitzer Capital Management sold 11,320 Teva Pharmaceuticals shares in Q3 2017, an estimated $376K.
  • Kornitzer Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
  • Kornitzer Capital Management's Teva Pharmaceuticals position peaked at $7.46M in Q1 2015.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Kornitzer Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.